Puerto, Jershon L.
HRN: 22-60-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/11/2023
04/17/2023
IV
600mg
Q6
DM Foot Wagner Grade 4
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes